Instead, they emerged from efforts in the early 2000s to improve treatment options for people with type 2 diabetes
Integrative Genomics Outlines a Biphasic Glucose Response and a ChREBP-RORgamma Axis Regulating Proliferation in beta Cells
For reasons that still aren't understood, the same drug works far better for some people than for others
A dose-related increase in benign thyroid C-cell adenomas was seen in the 1 and the 3 mg/kg/day groups with incidences of 13% and 19% in males and 6% and 20% in females, respectively
The drug companies believe that hitting more receptors induces better weight-loss effects, which does appear to be true, but when it comes to what this is doing across different immune populations, downstream signaling can be completely changed by adding on these extra agonists, she says
This dual mechanism means tirzepatide engages pathways that were not being stimulated by semaglutide, providing a form of receptor novelty